Status:
COMPLETED
KULeuven Intensive Insulin Therapy Study in Medical Intensive Care Patients
Lead Sponsor:
KU Leuven
Collaborating Sponsors:
Fund for Scientific Research, Flanders, Belgium
Novo Nordisk A/S
Conditions:
Critical Illness
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
In a previous study, we showed that tight blood glucose control with insulin during intensive care reduced morbidity and mortality of surgical intensive care patients. Whether this intervention also i...
Detailed Description
In a previous study, we showed that tight blood glucose control with insulin during intensive care reduced morbidity and mortality of surgical intensive care patients. Whether this intervention also i...
Eligibility Criteria
Inclusion
- Adults admitted to ICU and anticipated to require intensive care for at least a few days
Exclusion
- Expected short ICU stay
- Therapy restricted upon admission
- Surgical ICU patients
- Other studies
- Below 18 years
- Pregnancy
Key Trial Info
Start Date :
March 1 2002
Trial Type :
INTERVENTIONAL
End Date :
June 1 2005
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT00115479
Start Date
March 1 2002
End Date
June 1 2005
Last Update
May 4 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Catholic University of Leuven, University Hospital Gasthuisberg
Leuven, Belgium, B-3000